Shreyas P. Vaidya - Publications

Affiliations: 
Tata Institute of Fundamental Research, Mumbai, Maharashtra, India 

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 M M, Chhatar S, Gadre S, Paul S, Vaidya SP, Khatri S, Duari P, Kode J, Ingle A, Kolthur-Seetharam U, Patra M. Improving In Vivo Tumor Accumulation and Efficacy of Platinum Antitumor Agents by Electronic Tuning of the Kinetic Lability. Chemistry (Weinheim An Der Bergstrasse, Germany). e202302720. PMID 37888749 DOI: 10.1002/chem.202302720  0.566
2023 Panda TR, Manikandan M, Vaidya SP, Chhatar S, Sinha S, Mehrotra M, Chakraborty S, Gadre S, Duari P, Ray P, Patra M. The Power of Kinetic Inertness in Improving Platinum Anticancer Therapy by Circumventing Resistance and Ameliorating Nephrotoxicity. Angewandte Chemie (International Ed. in English). e202303958. PMID 37314332 DOI: 10.1002/anie.202303958  0.601
2022 Vaidya SP, Patra M. Platinum glycoconjugates: "Sweet bullets" for targeted cancer therapy? Current Opinion in Chemical Biology. 72: 102236. PMID 36516491 DOI: 10.1016/j.cbpa.2022.102236  0.633
2022 Vaidya SP, Gadre S, Teja KR, Patra M. Challenges and opportunities in the development of metal-based anticancer theranostic agents. Bioscience Reports. PMID 35420649 DOI: 10.1042/BSR20212160  0.583
2021 Patra M, Vaidya SP. X-rays actuate anticancer drugs: Opening new vistas in prodrug therapy. Chembiochem : a European Journal of Chemical Biology. PMID 34406685 DOI: 10.1002/cbic.202100373  0.542
Show low-probability matches.